About APT Comparison

This study compares the clinical effectiveness of Atogepant to Topiramate and Propranolol among adults who have migraine.

Migraine affects approximately 14% of the U.S. population. Results from this study will be informative to adults, clinicians, payers and policy makers as they consider ways to select amongst migraine preventive medication options and shorten the time required to find an effective and tolerable treatment for individuals with migraine.